|
As reported, 2 day post mesh implant, the patient experienced symptoms that would later be identified as a bowel obstruction, adhesion and subsequently underwent surgical intervention for mesh removal.Multiple attempts have been made to obtain additional information; however, no additional details have been provided.Based on the information provided to date, no conclusion can be made as to the degree to which the bard device, may be causing or contributing the patient¿s reported symptoms.A review of the manufacturing records was performed and found that the lot was manufactured to specification.To date, this is the only reported complaint for this manufacturing lot of (b)(4) units released for distribution in july 2019.Adhesion is identified as a potential complication in the instructions-for-use (ifu).In regards to mesh placement, the warnings section of the ifu states: "ensure proper orientation; the coated side of ventralight st mesh with echo ps positioning system should be oriented against the bowel or sensitive organs.Do not place the polypropylene side against the bowel.There is a possibility for adhesion formation when the polypropylene side is placed in direct contact with the bowel or viscera." sample not available.
|